Please login to read the full article.
Scrip Regulatory Affairs
EU in danger of double standards as generics association calls for IP work-around
18 May 2011
Francesca Bruce
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- EU parliament could do away with global anti-counterfeit agreement by summer
- Higher US generic drugs user fee for foreign units 'discriminatory, anti-competitive', say Indian firms
- Indian firms fear US generic user fee would raise the cost of business
- More Indian drugs detained in EU as FTA talks progress ahead of summit
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
